Replies to post #333804 on NorthWest Biotherapeutics Inc (NWBO)

[Sojourner55]

Great find. Looks like NYSE listing plans in the works.

[BioInvestor4]

Great find!

“Bruce Poignant Managing Director, Global Corporate Client Group primarily responsible for growth of the NYSE MKT listings platform.”

[VikingInvest]

Looks promising. I know LP has mentioned she prefer NYSE, but we are not close to a listing there, but could re-list on NASDAQ fairly soon if she wanted to.

[biosectinvestor]

Very interesting. Good eye!

[Survivor2012]

Hmuney, when I go to the 2 sites you posted, I do not see/read the connection between Poignant and NWBO. Please help. TIA.

[Harry1969]

I think he’s been on there for a few years? The link below is an archived page from 2017:

https://web.archive.org/web/20170729033528/https://www.otcmarkets.com/stock/NWBO/profile

[ATLnsider]

Thanks hmuney...

[br8k0ut]

Thanks man!

[anders2211]

Great find

I would never choose that name for my consultancy firm:

https://www.donohoeadvisory.com/


dont know how advisory

anyway they are specialized in

We have an extensive understanding of NASDAQ, NYSE, and NYSE Amex listing requirements, practices, and policies – both written and unwritten.

so it does NWBO is preparing in that direction after TLD. Interesting

[Dr Bala]

Thanks for the great find: Bruce Poignant now a consultant for NWBO.

Donohoe Advisory was founded by Dave Donohoe in 2004, and since that time the firm has successfully represented nearly 1,000 companies in a wide range of listing matters at both The Nasdaq Stock Market (“Nasdaq”) and the New York Stock Exchange (the “NYSE”). Each professional member of Donohoe Advisory’s team previously worked for either Nasdaq or the NYSE. Prior to forming Donohoe Advisory, Dave Donohoe spent 9+ years with Nasdaq, where he ultimately served as Chief Counsel in the Listing Qualifications Department. He is joined by Bruce Poignant, a 25-year Exchange veteran, together with a team of former Exchange officials.

Ref.: https://www.globenewswire.com/news-release/2019/07/02/1877348/0/en/Generex-Engages-Donohoe-Advisory-to-Assist-with-Uplisting.html